Hims & Hers Files Q1 2025 10-Q
Ticker: HIMS · Form: 10-Q · Filed: 2025-05-05T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, healthcare
Related Tickers: HIMS
TL;DR
HIMS Q1 2025 10-Q filed. Financials and operations updated.
AI Summary
Hims & Hers Health, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business segments are presented, reflecting the company's ongoing activities in the health and wellness sector.
Why It Matters
This filing provides investors with the latest financial health and operational performance of Hims & Hers, crucial for understanding the company's trajectory in the competitive telehealth market.
Risk Assessment
Risk Level: medium — The company operates in a dynamic and competitive telehealth market, subject to regulatory changes and evolving consumer demand.
Key Numbers
- 2.083 — Shares Outstanding (Represents the number of shares outstanding as of the reporting period.)
Key Players & Entities
- Hims & Hers Health, Inc. (company) — Filer of the 10-Q
- Oaktree Acquisition Corp. (company) — Former name of Hims & Hers Health, Inc.
- 20250331 (date) — End of the reporting period
- 20250505 (date) — Filing date of the 10-Q
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 5, 2025.
What was the former name of Hims & Hers Health, Inc.?
The former name of Hims & Hers Health, Inc. was Oaktree Acquisition Corp.
What is the fiscal year end for Hims & Hers Health, Inc.?
The fiscal year end for Hims & Hers Health, Inc. is December 31.
What is the SIC code for Hims & Hers Health, Inc.?
The Standard Industrial Classification (SIC) code for Hims & Hers Health, Inc. is 8011, which falls under SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE.
From the Filing
0001773751-25-000154.txt : 20250505 0001773751-25-000154.hdr.sgml : 20250505 20250505161734 ACCESSION NUMBER: 0001773751-25-000154 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 116 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250505 DATE AS OF CHANGE: 20250505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 25913214 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 10-Q 1 hims-20250331.htm 10-Q hims-20250331 FALSE 2025 Q1 0001773751 12/31 P4Y 2.083 2.083 4/1/2026 300 xbrli:shares iso4217:USD iso4217:USD xbrli:shares hims:reportingUnit xbrli:pure hims:commonStockClass utr:D hims:Facility 0001773751 2025-01-01 2025-03-31 0001773751 us-gaap:CommonClassAMember 2025-05-02 0001773751 hims:CommonClassVMember 2025-05-02 0001773751 2025-03-31 0001773751 2024-12-31 0001773751 us-gaap:CommonClassAMember 2024-12-31 0001773751 us-gaap:CommonClassAMember 2025-03-31 0001773751 hims:CommonClassVMember 2024-12-31 0001773751 hims:CommonClassVMember 2025-03-31 0001773751 2024-01-01 2024-03-31 0001773751 us-gaap:CommonStockMember 2024-12-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001773751 us-gaap:RetainedEarningsMember 2024-12-31 0001773751 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001773751 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001773751 us-gaap:CommonStockMember 2025-03-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001773751 us-gaap:RetainedEarningsMember 2025-03-31 0001773751 us-gaap:CommonStockMember 2023-12-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001773751 us-gaap:RetainedEarningsMember 2023-12-31 0001773751 2023-12-31 0001773751 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001773751 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001773751 us-gaap:CommonStockMember 2024-03-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001773751 us-gaap:RetainedEarningsMember 2024-03-31 0001773751 2024-03-31 0001773751 hims:SigmundNJLLCTrybeLabsMember 2025-01-01 2025-03-31 0001773751 us-gaap:SalesChannelDirectlyToConsumerMember 2025-01-01 2025-03-31 0001773751 us-gaap:SalesChannelDirectlyToConsumerMember 2024-01-01 2024-03-31 0001773751 us-gaap:SalesChannelThroughIntermediaryMember 2025-01-01 2025-03-31 0001773751 us-gaap:SalesChannelThroughIntermediaryMember 2024-01-01 2024-03-31 0001773751 hims:CSBioCo.Member 2025-02-01 2025-02-28 0001773751 srt:MaximumMember hims:CSBioCo.Member 2025-02-01 2025-02-28 0001773751 hims:CSBioCo.Member 2025-02-28 0001773751 hims:SigmundNJLLCTrybeLabsMember 2025-02-01 2025-02-28 0001773751 hims:SeaviewEnterprisesLLCMedisourceRxMember 2024-09-01 2024-09-30 0001773751 hims:SeaviewEnterprisesLLCMedisourceRxMember 2024-09-30 0001773751 2024-09-30 0001773751 hims:SeaviewEnterprisesLLCMedisourceRxMem